Avicanna Completes Export Of CBD Isolate And Full Spectrum CBD From Colombia To Chile

CBD-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) said Friday it has completed a commercial export of CBD Isolate and CBD full spectrum psychoactive cannabis resin to a leading Chilean homeopathic and naturopathic pharmaceutical company through Santa Marta Golden Hemp (SMGH) S.A.S., its Colombian subsidiary.

Designed to supply partner companies and manufacture Avicanna’s own finished products, Cannabis Derivatives - branded as Aureus - are cultivated, extracted and manufactured at a cultivation and extraction infrastructure in Santa Marta, Colombia.

SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG, the Toronto-based company confirmed.

This new export to Chile is a recurring order and part of an ongoing relationship with an established homeopathic Chilean company.

Recent news from Avicanna:

• Avicanna Raises $3.2M Via Non-Brokered Offering, Announces Warrant Repricing
• Avicanna Ships Its Feminized Cannabis Seeds To Peru And Argentina
• Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
• Avicanna Completes Registration And Commercial Export Of Pura Earth CBD Brand In Ecuador
• Avicanna Reaches Brazil With Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts

Photo: Courtesy of Kindel Media